ReviewEndocrine, metabolic & immune disorders drug targets2026
Metabolomics: A Viable Approach to Understand the Pathogenesis of Reactive Arthritis
Review in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactive arthritis (ReA) is characterized by immune-mediated sterile synovitis brought on by an infection that enters the body through the gastrointestinal or urogenital tracts from a distance. The diseases known as seronegative spondyloarthropathy (SSA) include undifferentiated arthritis (uSpA) and reactive arthritis (ReA). Cytokines are crucial in orchestrating an effective immune response to eliminate bacterial infections, such as those seen in ReA (Reactive Arthritis) conditions. The balance between Th1 and Th2 cytokines is particularly important in determining the outcome of infections associated with ReA. TNF-α and IFN-γ are key antibacterial Th1 cytokines that promote cell-mediated immunity, essential for effective cellular responses against intracellular bacteria. In contrast, Th2 cytokines like IL-4, IL-5, IL-9, and IL-13 are more involved in generating humoral immunity and allergic responses. The mechanisms underlying the differentiation of T helper lymphocytes, which lead to a skewed cytokine secretion profile, remain unclear. Several factors, including the local inflammatory environment, IL-12 levels during T cell priming, variations among antigen-presenting cells (APCs), and antigen dose, have been suggested as potential contributors. This review will explore the critical role of metabolomics in cytokine production and its profound impact on the pathogenesis of reactive arthritis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.